{"id": "1341308651022258177", "creation": 1608627877.0, "user_id": "1332324349039304714", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 1, "reply_count": 0, "like_count": 2, "quote_count": 0}}, "text": "Finally #GermanInnovation benefits #EUcitizens with @EMA_News approval of the @BioNTech_Group #COVID19 #vaccine! https://t.co/lXlRABZckX Founding investor &amp; active shareholder MIG is proud &amp; delighted! Innovation needs risk capital #VentureCapital #VisionsIntoValue", "first_save": 1634559108.199414, "hashtags": ["#GERMANINNOVATION", "#EUCITIZENS", "#COVID19", "#VACCINE", "#VENTURECAPITAL", "#VISIONSINTOVALUE"]}